TG Branfalt

Hightimes Holding Corp. disclosed doubts about the High Times magazine’s ability to continue operations due to “recurring operating losses, net operating cash flow deficits, and an accumulated deficit.”

New Mexico’s Economic Development Department this week announced a $200,000 investment into 420 Valley LLC, a Las Cruces-based hemp productions and processing plant.

Cannabis activists in North Dakota have submitted language for a legalization ballot initiative to the secretary of state; if approved, the group will need to collect 13,452 signatures by July 6 to put the issue on the 2020 ballot.

Chris Hagedorn is the general manager for Hawthorne Gardening Company, a business venture that provides all the cultivation needs of a state-legal cannabis operator.

New Zealand citizens will get to choose next year whether or not to legalize adult-use cannabis; lawmakers there just revealed parts of their legalization plan if the vote were to pass.

Virginia Attorney General Mark Herring is joining the Virginia Cannabis Caucus next week to discuss enacting major cannabis reforms in the state.

Federal regulators have removed barriers that blocked industrial hemp companies from accessing traditional financial services despite the crop’s federally legal status.

According to polling data from the major metro areas of Seattle, Portland, and San Francisco, there are more adults 18-and-older who have used cannabis recently than smoked cigarettes.

Brazil health regulators have approved a set of rules to allow for medical cannabis use; the rules, however, would not allow for domestic cultivation and the program would rely solely on imported cannabis products.

Gov. Albert Bryan of the U.S. Virgin Islands is considering adult-use cannabis legalization as a means of reinforcing the Government Employees’ Retirement System with $20 million in annual tax revenue.

Recent surveying data suggests that investors are evenly split between whether or not they would ever invest in the cannabis space.

Minnesota health officials have approved chronic pain and a degenerative eye condition as new qualifying conditions for the state’s medical cannabis program.

Criminal charges have not been dropped against a Brooklyn man who received a 106-pound shipment of hemp from Vermont; two weeks ago, police said the charges would be dropped after confirming the shipment to be hemp.

The Eastern Shoshone Tribe in Wyoming is pursuing a plan to legalize hemp and medical cannabis in an effort to diversify the Wind River Reservation economy and offer alternative medical treatments.

Green Leaf Health Inc. has reached a “host community agreement” with North Attleboro, Massachusetts. It will be the first cannabis company licensed for adult-use sales in the city.

Federal cannabis patient George McMahon passed away on Saturday, November 30, 2019 — he was one of the last three patients who still receive cannabis from the federal government.

A new FDA consumer update claims that CBD “has the potential to harm” and suggests that symptoms could range from potential mood swings to even male infertility.

New Jersey Gov. Phil Murphy has started a push for statewide cannabis decriminalization, even as lawmakers are positioning to put the legalization question to voters next year.

A panel of mostly Arizona medical cannabis industry operators is set to determine which pesticides should be allowed in the industry; any final decision must be approved by the Department of Health Services.

Two cannabis advocacy groups in Florida have submitted petition signatures for two different cannabis legalization proposals; prohibitionist advocates, meanwhile, have formed their own campaign to push back against cannabis reforms.

A self-reported cannabis consumer study from Washington State University suggests that inhaled cannabis products reduce the severity of headaches and migraines by 49.6 percent and 47.3 percent, respectively.

Senate Majority Leader Mitch McConnell recently met with FDA Commissioner nominee Dr. Stephen Hahn and discussed the need for a federal CBD regulatory framework.

Michigan regulators have declared a temporary ban on cannabis vaporizer products sold at dispensaries; officials also permanently banned the use of vitamin E acetate as a cutting agent in cannabis products.

Federal officials at the U.S. Substance Abuse and Mental Health Services Administration have prohibited any federal funds meant to combat opioid addiction from being used on medical cannabis.